Boston Scientific (BSX) Competitors $102.71 -1.63 (-1.56%) Closing price 03:59 PM EasternExtended Trading$103.00 +0.29 (+0.28%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BSX vs. ALGN, HOLX, HQY, MMSI, AMN, DVA, ECL, HCA, ITGR, and MDTShould you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Align Technology (ALGN), Hologic (HOLX), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), DaVita (DVA), Ecolab (ECL), HCA Healthcare (HCA), Integer (ITGR), and Medtronic (MDT). Boston Scientific vs. Its Competitors Align Technology Hologic HealthEquity Merit Medical Systems AMN Healthcare Services DaVita Ecolab HCA Healthcare Integer Medtronic Boston Scientific (NYSE:BSX) and Align Technology (NASDAQ:ALGN) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment. Do insiders and institutionals believe in BSX or ALGN? 89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 0.5% of Boston Scientific shares are owned by company insiders. Comparatively, 0.7% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has stronger valuation & earnings, BSX or ALGN? Boston Scientific has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBoston Scientific$16.75B9.09$1.85B$1.6861.14Align Technology$4.00B2.38$421.36M$5.9322.19 Does the media refer more to BSX or ALGN? In the previous week, Boston Scientific had 29 more articles in the media than Align Technology. MarketBeat recorded 57 mentions for Boston Scientific and 28 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.20 beat Align Technology's score of 1.17 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 36 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 17 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, BSX or ALGN? Boston Scientific has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Is BSX or ALGN more profitable? Boston Scientific has a net margin of 13.55% compared to Align Technology's net margin of 11.04%. Boston Scientific's return on equity of 19.21% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets Boston Scientific13.55% 19.21% 10.62% Align Technology 11.04%13.36%8.32% Do analysts rate BSX or ALGN? Boston Scientific currently has a consensus price target of $118.04, indicating a potential upside of 14.93%. Align Technology has a consensus price target of $215.00, indicating a potential upside of 63.42%. Given Align Technology's higher possible upside, analysts clearly believe Align Technology is more favorable than Boston Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Boston Scientific 0 Sell rating(s) 1 Hold rating(s) 22 Buy rating(s) 3 Strong Buy rating(s) 3.08Align Technology 2 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.50 SummaryBoston Scientific beats Align Technology on 13 of the 17 factors compared between the two stocks. Get Boston Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSX vs. The Competition Export to ExcelMetricBoston ScientificMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$154.61B$10.65B$5.79B$21.49BDividend YieldN/A1.85%5.69%3.53%P/E Ratio61.1421.1374.5929.70Price / Sales9.0931.03449.5451.73Price / Cash28.5824.7237.0824.52Price / Book6.883.5212.154.58Net Income$1.85B$210.50M$3.28B$1.00B7 Day Performance-4.14%-0.18%0.98%0.66%1 Month Performance0.17%3.91%7.20%4.64%1 Year Performance22.51%-10.02%63.06%15.96% Boston Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSXBoston Scientific4.7882 of 5 stars$102.71-1.6%$118.04+14.9%+26.1%$154.61B$16.75B61.1453,000Trending NewsAnalyst ForecastAnalyst RevisionALGNAlign Technology4.9547 of 5 stars$136.86-1.6%$215.00+57.1%-39.6%$9.92B$4.00B23.0820,945Positive NewsHOLXHologic4.9283 of 5 stars$66.54-0.3%$78.00+17.2%-17.0%$14.80B$4.03B27.617,063Positive NewsHQYHealthEquity4.436 of 5 stars$93.06+1.7%$119.77+28.7%+22.9%$8.02B$1.20B56.403,120Positive NewsMMSIMerit Medical Systems4.8155 of 5 stars$92.25-0.8%$107.00+16.0%-7.1%$5.46B$1.36B46.837,400Positive NewsAMNAMN Healthcare Services4.6366 of 5 stars$20.97+0.6%$28.25+34.7%-56.0%$803.61M$2.98B-2.702,968News CoverageAnalyst ForecastShort Interest ↓Analyst RevisionDVADaVita4.6588 of 5 stars$134.44-2.5%$164.00+22.0%-13.4%$9.61B$12.82B13.2276,000Analyst ForecastECLEcolab4.9066 of 5 stars$275.21+0.6%$292.00+6.1%+10.4%$78.06B$15.74B36.7448,000Positive NewsHCAHCA Healthcare4.5702 of 5 stars$417.95-0.7%$401.83-3.9%+3.7%$97.80B$70.60B17.57316,000Positive NewsAnalyst ForecastITGRInteger3.859 of 5 stars$106.01-0.9%$140.25+32.3%-16.2%$3.71B$1.72B46.7011,000MDTMedtronic4.9311 of 5 stars$92.91+0.0%$102.14+9.9%+4.2%$119.17B$33.54B25.5995,000Positive News Related Companies and Tools Related Companies Align Technology Alternatives Hologic Alternatives HealthEquity Alternatives Merit Medical Systems Alternatives AMN Healthcare Services Alternatives DaVita Alternatives Ecolab Alternatives HCA Healthcare Alternatives Integer Alternatives Medtronic Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BSX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredWall Street laughed at Trump’s “Smart Dollar.” Now they’re all in."THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
